Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) Sees Significant Growth in Short Interest

Newron Pharmaceuticals S.p.A. (OTCMKTS:NWPHF) saw a significant increase in short interest during the month of November. As of November 30th, there was short interest totalling 100,700 shares, an increase of 15.5% from the November 15th total of 87,200 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Newron Pharmaceuticals Stock Performance

Shares of NWPHF opened at $9.36 on Tuesday. Newron Pharmaceuticals has a 12 month low of $9.10 and a 12 month high of $12.00. The company has a 50-day moving average price of $9.36 and a two-hundred day moving average price of $10.06.

About Newron Pharmaceuticals

Newron Pharmaceuticals S.p.A., a biopharmaceutical company, focus on the development of novel therapies for the treatment of central nervous system (CNS) and pain in Italy and the United States. It offers Xadago (safinamide), a chemical entity for the treatment of Parkinson's in the European Union, Switzerland, the United Kingdom, the United States of America, Australia, Canada, Latin America, Israel, the United Arab Emirates, Japan, and South Korea.